Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
OneSpaWorld Holdings (OSW) has been tapped by Niagen Bioscience as the newest Niagen Plus provider, bringing pharmaceutical grade Niagen IV to more than 80 Medi-Spa clinics across high-end cruise ships.
This agreement adds a branded IV therapy service to OneSpaWorld’s existing onboard wellness menu, tied to Niagen’s wider clinical distribution through over 1,200 healthcare, wellness, and longevity clinics across the U.S.
See our latest analysis for OneSpaWorld Holdings.
The Niagen Bioscience announcement lands at a time when momentum in OneSpaWorld’s shares has been building, with a 30 day share price return of 14.99% and a 1 year total shareholder return of 55.43% reinforcing a stronger multi year trend.
If this wellness partnership has caught your eye, it could be a good moment to broaden your watchlist and check out 20 top founder-led companies
With OneSpaWorld shares up 55.43% over the past year and trading around $23.48, just under a $26.80 analyst target yet at an intrinsic premium, are you looking at fresh upside here, or has the market already priced in future growth?
With OneSpaWorld closing at $23.48 against a narrative fair value of $26.60, the current price sits below what this widely followed model implies.
Strong consumer demand for wellness and self-care, reflected in higher onboard spend and robust adoption of premium services (e.g. medi-spa, IV therapy, innovative treatments), provides ongoing pricing power and opportunity for upselling, supporting both top-line revenue and higher net margins.
Curious what level of revenue growth, margin expansion, and future earnings multiple need to stack together to reach that $26.60 fair value? The narrative connects cruise guest spending, premium wellness uptake, and long term profitability into one tight valuation story.
Result: Fair Value of $26.60 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this story can change quickly if cruise volumes weaken or if higher regulatory and compliance costs pressure the roughly 9.5% margin framework that analysts are using.
Find out about the key risks to this OneSpaWorld Holdings narrative.
The narrative model sees OneSpaWorld as 12% undervalued, yet the current P/E of 33.3x is far higher than the US Consumer Services average of 18.1x, the peer average of 13.2x, and even the 20.9x fair ratio that the market could gravitate toward over time.
That kind of gap can work out well if the growth story plays out cleanly. However, it also raises the risk that even a small reset in expectations or sentiment could drag the multiple closer to peers. How much valuation stretch are you personally comfortable owning?
See what the numbers say about this price — find out in our valuation breakdown.
NasdaqCM:OSW P/E Ratio as at Apr 2026
Reading through all this, are you sensing more promise or more risk here? Take a closer look now and weigh those positives for yourself with 1 key reward
If OneSpaWorld has sharpened your thinking, do not stop here. Widen your search now so you are not relying on a single opportunity.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OSW.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
